Doctors at the University of Maryland Medical Center are using a new cryotherapy technique to treat cancerous and precancerous conditions of the esophagus.
Doctors who treat the painful condition of osteoarthritis in patients with increased cardiovascular risk need to be cautious.
A senior UK oncologist Chris Hamilton admitted that thousands of men with prostate cancer are being given unnecessary and potentially harmful drug treatment to clear hospital waiting lists in UK.
The Food and Drug Administration (FDA) is urgently reminding the public that contact with baby turtles can pose a serious health risk to infants, small children, and adults with impaired immune systems as they can be natural hosts to Salmonella, a group of bacteria that can cause severe illness and death.
The common painkiller, ibuprofen, may boost the likelihood of heart problems in high risk patients who have osteoarthritis, suggests research published ahead of print in the Annals of the Rheumatic Diseases.
People with physical disabilities endure substandard health care and a pervasive sense that they are a burden to doctors, according to a Northwestern University physician who is lead author of a commentary in JAMA. These patients often ram into roadblocks when they try to obtain basic care and life-saving diagnostic tests, reports Kristi Kirschner, M.D. Patients and health care workers have been injured because of inadequate facilities. Kirschner offers an overdue blueprint for change.
Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), and Lundbeck A/S presented clinical study results on bifeprunox at an international medical congress this week.
The European Commission approved Xeloda in combination with platinum-based chemotherapy, for first-line use in patients with advanced stomach cancer.
Schering-Plough Corporation (NYSE: SGP) announced that prescription-strength MiraLAX? (polyethylene glycol 3350) is now available as an over-the-counter (OTC) treatment for occasional constipation.
Long waits for endoscopies have been eliminated in many parts of the UK, but some people are still waiting too long for the procedures, particularly in the south east, according to a report published by the Healthcare Commission, UK.